AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1872348 — intervention group
Group type: COMPARATOR
Intervention: Usual history question (oral and written)
Number of subjects: 1078
Study 1872348 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical tests of urine samples from reported nonsmokers
Number of subjects: 1078
Study 1872348 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsmokers in experimental groups
Number of subjects: 1078
Study 31771375 — intervention group
Group type: EXPERIMENTAL
Intervention: High perceived family support
Number of subjects: 371
Study 31771375 — intervention group
Group type: COMPARATOR
Intervention: Low perceived family support
Number of subjects: 371
Study 31771375 — intervention group
Group type: EXPERIMENTAL
Intervention: Controller medication use (≥8 days over 2 weeks)
Number of subjects: 371
Study 31771375 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma control
Number of subjects: 371
Study 31487819 — intervention group
Group type: EXPERIMENTAL
Intervention: Native whey (20 g, 2 servings daily)
Number of subjects: 30
Study 31487819 — intervention group
Group type: COMPARATOR
Intervention: Milk protein (20 g, 2 servings daily)
Number of subjects: 30
Study 28679741 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet transfusions
Number of subjects: 1077
Study 28679741 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of platelets or RBCs
Number of subjects: 1077
Study 26222447 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS-methylphenidate
Number of subjects: 160
Study 26222447 — intervention group
Group type: EXPERIMENTAL
Intervention: atomoxetine
Number of subjects: 160
Study 24191395 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy (coronary arteriography and percutaneous coronary intervention within 24 hours after admission)
Number of subjects: 178
Study 24191395 — intervention group
Group type: COMPARATOR
Intervention: Selective invasive strategy (medically stabilized, coronary arteriography only if angina recurrence or evidence of inducible myocardial ischemia)
Number of subjects: 178
Study 20674309 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 27
Study 19204019 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady/non‐steady concurrency
Number of subjects: 973
Study 19204019 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent condom use with non‐steady partners
Number of subjects: 973
Study 17718369 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic tone complexes with fundamental frequencies of 110 Hz and 185 Hz, tested before and after selective adaptation.
Number of subjects: 19
Study 17718369 — intervention group
Group type: EXPERIMENTAL
Intervention: Unresolved adaptor stimuli presented with a diotic noise background.
Number of subjects: 19
Study 17718369 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially resolved adaptor stimuli presented with a diotic noise background.
Number of subjects: 19
Study 15172104 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease patients (AD)
Number of subjects: 51
Study 15172104 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hippocampal T(2) in AD patients
Number of subjects: 51
Study 15172104 — intervention group
Group type: EXPERIMENTAL
Intervention: Amygdaloid T(2) in AD patients
Number of subjects: 51
Study 15172104 — intervention group
Group type: COMPARATOR
Intervention: Vascular dementia subjects (VaD)
Number of subjects: 51
Study 15172104 — intervention group
Group type: COMPARATOR
Intervention: Healthy elderly controls
Number of subjects: 51
Study 11601666 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive asthma education and monitoring program
Number of subjects: 22
Study 11601666 — intervention group
Group type: COMPARATOR
Intervention: Routine dispensing services
Number of subjects: 22
Study 9884175 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathy
Number of subjects: 1778
Study 9884175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1778
Study 8118992 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma spray cementless THR (Mallory‐Head)
Number of subjects: 0
Study 8118992 — intervention group
Group type: COMPARATOR
Intervention: Sintered bead cementless THR (PCA)
Number of subjects: 0
Study 8118992 — intervention group
Group type: COMPARATOR
Intervention: Cemented THR
Number of subjects: 0
Study 2563606 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin (40 mg daily for 4 weeks, then individually adjusted for 8 weeks)
Number of subjects: 168
Study 2563606 — intervention group
Group type: COMPARATOR
Intervention: Etretinate (40 mg daily for 4 weeks, then individually adjusted for 8 weeks)
Number of subjects: 168
Study 2563606 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin
Number of subjects: 168
Study 2563606 — intervention group
Group type: COMPARATOR
Intervention: Etretinate
Number of subjects: 168
Study 1100535 — intervention group
Group type: EXPERIMENTAL
Intervention: Demetrin 3 x 10 mg/day
Number of subjects: 0
Study 1100535 — intervention group
Group type: EXPERIMENTAL
Intervention: Demetrin 3 x 20 mg/day
Number of subjects: 0
Study 1100535 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31767043 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care with shunt strategy
Number of subjects: 320
Study 31767043 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoiding deep hypothermic circulatory arrest
Number of subjects: 320
Study 31767043 — intervention group
Group type: EXPERIMENTAL
Intervention: Centres with fewer patients with prolonged pleural effusion (<6%) and fewer complications (<41%)
Number of subjects: 320
Study 28606176 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab-containing reduced-intensity conditioning (R-RIC)
Number of subjects: 1401
Study 28606176 — intervention group
Group type: COMPARATOR
Intervention: Non-rituximab-containing reduced-intensity conditioning (nonR-RIC)
Number of subjects: 1401
Study 26702086 — intervention group
Group type: EXPERIMENTAL
Intervention: Statewide public and health professional awareness campaign to increase regular aspirin use
Number of subjects: 0
Study 26702086 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 0
Study 24084510 — intervention group
Group type: EXPERIMENTAL
Intervention: Violent video game playing
Number of subjects: 48
Study 24084510 — intervention group
Group type: COMPARATOR
Intervention: Non-violent video game playing
Number of subjects: 48
Study 24084510 — intervention group
Group type: COMPARATOR
Intervention: Watching TV
Number of subjects: 48
Study 21521834 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (80 mg daily) administered concomitantly (CONC)
Number of subjects: 20
Study 21521834 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (80 mg daily) administered staggered by 8 to 12 hours (STAG)
Number of subjects: 20
Study 21521834 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel-only regimen
Number of subjects: 20
Study 18996507 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine hydrochloride (0.5 mg/kg)
Number of subjects: 26
Study 17060379 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic waveform shocks
Number of subjects: 168
Study 17060379 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic waveform shocks
Number of subjects: 168
Study 12935797 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg tolperisone hydrochloride
Number of subjects: 15
Study 12935797 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg pridinol mesilate
Number of subjects: 15
Study 12935797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 11122503 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry visco-elastic polymer pad
Number of subjects: 446
Study 11122503 — intervention group
Group type: COMPARATOR
Intervention: Standard foam mattress
Number of subjects: 446
Study 8603261 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide treatment (n=16)
Number of subjects: 39
Study 8603261 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide treatment in patients with HIV‐1 and tuberculosis infections
Number of subjects: 39
Study 8603261 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (n=16)
Number of subjects: 39
Study 8603261 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide treatment in patients with HIV‐1 infection only
Number of subjects: 39
Study 1584941 — intervention group
Group type: EXPERIMENTAL
Intervention: Amebicidal therapy coupled with image-guided percutaneous therapeutic aspiration
Number of subjects: 41
Study 1584941 — intervention group
Group type: COMPARATOR
Intervention: Amebicidal therapy alone
Number of subjects: 41
Study 2858420 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 24
Study 2858420 — intervention group
Group type: EXPERIMENTAL
Intervention: Mequitazine
Number of subjects: 24
Study 2858420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2858420 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin vs Mequitazine
Number of subjects: 24
Study 31876012 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning-centered group psychotherapy for cancer survivors (MCGP-CS)
Number of subjects: 170
Study 31876012 — intervention group
Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 170
Study 31876012 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 170
Study 28967323 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard crisis response plan (S-CRP), N=32
Number of subjects: 97
Study 28967323 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced crisis response plan (E-CRP), N=33
Number of subjects: 97
Study 28967323 — intervention group
Group type: COMPARATOR
Intervention: Contract for safety, N=32
Number of subjects: 97
Study 27506585 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (500 mg/8 h) over 6 weeks
Number of subjects: 65
Study 27506585 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular leukocyte-poor PRP (LP-PRP) injections (three injections, once every 2 weeks)
Number of subjects: 65
Study 24819349 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping® (KT)
Number of subjects: 94
Study 24819349 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study 22310408 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) scans
Number of subjects: 24
Study 22310408 — intervention group
Group type: COMPARATOR
Intervention: Plain radiographs
Number of subjects: 24
Study 20620261 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic announcement protocol (P)
Number of subjects: 31
Study 20620261 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Appraisal of Illness Questionnaire (SAIQ)
Number of subjects: 31
Study 20620261 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive and Negative Syndrome Scale (PANSS)
Number of subjects: 31
Study 20620261 — intervention group
Group type: COMPARATOR
Intervention: Control group (SP)
Number of subjects: 31
Study 18591575 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (d-amph) 10 mg single dose
Number of subjects: 20
Study 24453535 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 36
Study 24453535 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 36
Study 24453535 — intervention group
Group type: COMPARATOR
Intervention: Sedentary Control (C)
Number of subjects: 36
Study 12060506 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg single dose of itraconazole
Number of subjects: 50
Study 12060506 — intervention group
Group type: COMPARATOR
Intervention: 7-day 200 mg daily dose of itraconazole
Number of subjects: 50
Study 10221945 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 372
Study 10221945 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 372
Study 10221945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study 10221945 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling and emotional support (combined with active drug)
Number of subjects: 372
Study 10221945 — intervention group
Group type: COMPARATOR
Intervention: Counselling and emotional support (simple psychological treatment)
Number of subjects: 372
Study 10221945 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender response
Number of subjects: 372
Study 10221945 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent depression
Number of subjects: 372
Study 10221945 — intervention group
Group type: EXPERIMENTAL
Intervention: First episode of depression
Number of subjects: 372
Study 7884414 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (4 cycles of chemotherapy for 3 months before surgery followed by 4 cycles after surgery)
Number of subjects: 212
Study 7884414 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant therapy (8 cycles of chemotherapy over 6 months after surgery)
Number of subjects: 212
Study 2144492 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-treated graft
Number of subjects: 20
Study 2144492 — intervention group
Group type: COMPARATOR
Intervention: Ordinary Dacron graft
Number of subjects: 20
Study 2144492 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 375459 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus anticoagulants
Number of subjects: 24
Study 375459 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 24
Study 31269917 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support for 12 months
Number of subjects: 226
Study 31269917 — intervention group
Group type: COMPARATOR
Intervention: No peer support (control)
Number of subjects: 226
Study 29957101 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol Valerate/Dienogest (EV/DNG)
Number of subjects: 341
Study 29957101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study 27373329 — intervention group
Group type: EXPERIMENTAL
Intervention: Bet v 1 COPs 50 μg
Number of subjects: 239
Study 27373329 — intervention group
Group type: EXPERIMENTAL
Intervention: Bet v 1 COPs 100 μg
Number of subjects: 239
Study 27373329 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline and aluminum hydroxide)
Number of subjects: 239
Study 25237124 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 12
Study 25237124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 21971535 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (12 sessions, 1 h/week) in psychology private practices
Number of subjects: 138
Study 21971535 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy in a small county hospital
Number of subjects: 138
Study 21971535 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 138
Study 21971535 — intervention group
Group type: COMPARATOR
Intervention: Waiting list controls
Number of subjects: 138
Study 21971535 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (study 1)
Number of subjects: 138
Study 21971535 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (study 2)
Number of subjects: 138
Study 21156074 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted preoperative planning and peri-operative patient-specific surgical guides
Number of subjects: 0
Study 21156074 — intervention group
Group type: COMPARATOR
Intervention: Conventional preoperative planning
Number of subjects: 0
Study 17653314 — intervention group
Group type: EXPERIMENTAL
Intervention: Singulair 4 mg once daily for 12 weeks
Number of subjects: 37
Study 17653314 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide aerosol 200 ug once or twice daily for 12 weeks
Number of subjects: 37
Study 17653314 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy infants)
Number of subjects: 37
Study 15584062 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term radiotherapy followed by TME
Number of subjects: 924
Study 15584062 — intervention group
Group type: COMPARATOR
Intervention: TME alone
Number of subjects: 924
Study 12090310 — intervention group
Group type: EXPERIMENTAL
Intervention: Family preservation program (FP Program)
Number of subjects: 0
Study 12090310 — intervention group
Group type: COMPARATOR
Intervention: 5-day residential program (5DR Program)
Number of subjects: 0
Study 10069193 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg, once daily for 8 weeks)
Number of subjects: 27
Study 10069193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 8528112 — intervention group
Group type: EXPERIMENTAL
Intervention: Conducting liquid
Number of subjects: 0
Study 8528112 — intervention group
Group type: COMPARATOR
Intervention: Non-conducting liquid
Number of subjects: 0
Study 1663226 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (0.3 mg/kg bodyweight)
Number of subjects: 20
Study 1663226 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study 7128670 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 0.125 mg and 0.250 mg via pressurized aerosol with pear-shaped spacer
Number of subjects: 13
Study 7128670 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline 1.25 mg and 2.50 mg via nebulized solution
Number of subjects: 13
Study 7128670 — intervention group
Group type: COMPARATOR
Intervention: Initial placebo treatment for both groups
Number of subjects: 13
Study 31274152 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically guided LV lead placement with post-implant VVd optimization
Number of subjects: 122
Study 31274152 — intervention group
Group type: COMPARATOR
Intervention: Imaging-guided LV lead implantation (control group)
Number of subjects: 122
Study 31274152 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122
Study 31274152 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically guided CRT implantation
Number of subjects: 122
Study 29049868 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense intervention group (home-based assessments at 6-month intervals and a 12-month multidisciplinary program with weekly group sessions)
Number of subjects: 203
Study 29049868 — intervention group
Group type: COMPARATOR
Intervention: Minimal-intensity control group (home-based assessments and advice at each 6-month follow-up)
Number of subjects: 203
Study 29049868 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense intervention group (with ≥70% attendance)
Number of subjects: 203
Study 29049868 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 203
Study 25627090 — intervention group
Group type: EXPERIMENTAL
Intervention: CFH +/+ HTRA1 -/-
Number of subjects: 2982
Study 25627090 — intervention group
Group type: EXPERIMENTAL
Intervention: CFH -/- HTRA1 +/+
Number of subjects: 2982
Study 25627090 — intervention group
Group type: EXPERIMENTAL
Intervention: CFH +/+ HTRA1 +/+
Number of subjects: 2982
Study 24397584 — intervention group
Group type: EXPERIMENTAL
Intervention: saxagliptin + metformin
Number of subjects: 858
Study 24397584 — intervention group
Group type: COMPARATOR
Intervention: glipizide + metformin
Number of subjects: 858
Study 22809843 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin resistance defined by response to arachidonic acid after 3, 5 and 7 minutes (approximately 30% of patients)
Number of subjects: 169
Study 22809843 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin resistance defined by response to adenosine diphosphate after 3 minutes (approximately 17% of patients)
Number of subjects: 169
Study 22809843 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin resistance (49 patients)
Number of subjects: 169
Study 22809843 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet CD62P expression at rest
Number of subjects: 169
Study 22809843 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet CD62P expression stimulated by arachidonic acid
Number of subjects: 169
Study 22809843 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet CD62P expression stimulated by adenosine diphosphate
Number of subjects: 169
Study 22809843 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin resistance in patients with greatest renal disease
Number of subjects: 169
Study 20186975 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/day + Depression Care Management (DCM) + Interpersonal Psychotherapy (IPT) for 16 weekly sessions
Number of subjects: 124
Study 20186975 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram 20 mg/day + Depression Care Management (DCM) without IPT
Number of subjects: 124
Study 18082522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low amount/moderate intensity exercise (equivalent to walking approximately 19 km/week)
Number of subjects: 171
Study 18082522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low amount/vigorous intensity exercise (equivalent to jogging approximately 19 km/week)
Number of subjects: 171
Study 18082522 — intervention group
Group type: EXPERIMENTAL
Intervention: High amount/vigorous intensity exercise (equivalent to jogging approximately 32 km/week)
Number of subjects: 171
Study 18082522 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 171
Study 18082522 — intervention group
Group type: COMPARATOR
Intervention: Inactive controls
Number of subjects: 171
Study 16253070 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of norfloxacin
Number of subjects: 234
Study 16253070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 16253070 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall infection rate after FC
Number of subjects: 234
Study 12693324 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with Praziquantel (25-50 mg/kg for 14 days)
Number of subjects: 136
Study 12693324 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment only
Number of subjects: 136
Study 9949745 — intervention group
Group type: EXPERIMENTAL
Intervention: Reach for Health Community Youth Service (CYS) program
Number of subjects: 1061
Study 9949745 — intervention group
Group type: EXPERIMENTAL
Intervention: Reach for Health classroom curriculum only
Number of subjects: 1061
Study 9949745 — intervention group
Group type: COMPARATOR
Intervention: Control condition (students at the other school)
Number of subjects: 1061
Study 7588990 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal Apomorphine
Number of subjects: 7